Revision history of "Liver organ fibrosis"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 11:20, 14 April 2024Waiterera38 (Talk | contribs). . (3,439 bytes) (+3,439). . (Created page with "5 publications noted the outcomes of 7 RCTs (3938 patients, 67.09% women). In comparison with INFβ-1a, ocrelizumab reduced potential risk of ARR (Three quarter Equates to 3.F...")